# Osteolife Biomedical I LLC, Miami, FL – FDA Inspections

Source: https://www.keypedia.com/companies/osteolife-biomedical-i-llc/65c313b4-28a5-4ecc-875c-ac366081fdc2

> Inspection records and compliance data for Osteolife Biomedical I LLC in Miami, Florida. 4 FDA inspections on record (1 OAI), 3 Form 483s, 1 warning letter, last inspected February 13, 2026.

---

## Details

- Name: Osteolife Biomedical I LLC
- FEI Number: 3014623896
- Address Line 1: 1951 Nw 7th Ave Sanibel Suite
- City: Miami
- State: Florida
- Zip Code: 33136
- Country Name: United States
- Address: 1951 Nw 7th Ave Sanibel Suite, Miami, Florida 33136, United States
- Country: United States

## Related Documents

- [FDA Inspection 1302716 - Osteolife Biomedical I LLC - 2026-02-13](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/cc42555d-bb87-4991-9795-ca2e6e41f2c6) — source: FDA, date: February 13, 2026
- [483 - Osteolife Biomedical I LLC - 2023-02-14](https://www.keypedia.com/records/483/osteolife-biomedical-i-llc/7826a380-a81e-424c-bc75-8f659fa18bf9) — source: FDA, date: February 14, 2023
- FDA Inspection 1197358 - Osteolife Biomedical I LLC - 2023-02-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 14, 2023
- [FDA Inspection 1197358 - Osteolife Biomedical I LLC - 2023-02-14](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/eef2a42a-0d42-4d5a-a386-6797bcbfc617) — classification: No Action Indicated (NAI), source: FDA, date: February 14, 2023
- [483 - Osteolife Biomedical I LLC - 2022-02-04](https://www.keypedia.com/records/483/osteolife-biomedical-i-llc/cec4e92c-49e4-4e6c-b669-0fa75e50103a) — source: FDA, date: February 4, 2022
- [WARNING_LETTER - Osteolife Biomedical I LLC - 2022-02-04](https://www.keypedia.com/records/warning_letter/osteolife-biomedical-i-llc/24458929-f02e-481c-af69-9cb14309ebbb) — source: FDA, date: February 4, 2022
- [FDA Inspection 1161595 - Osteolife Biomedical I LLC - 2022-02-04](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/6bfd2c91-c8f3-4587-9338-090c61ef0329) — classification: Official Action Indicated (OAI), source: FDA, date: February 4, 2022
- FDA Inspection 1161595 - Osteolife Biomedical I LLC - 2022-02-04 — classification: No Action Indicated (NAI), source: FDA, date: February 4, 2022
- [FDA Inspection 1072837 - Osteolife Biomedical I LLC - 2018-11-28](https://www.keypedia.com/records/fda_inspections/osteolife-biomedical-i-llc/32fed49c-542d-4511-bac7-6f630477eced) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 28, 2018

## Related Companies

- [Octapharma Plasma, Inc.](https://www.keypedia.com/companies/octapharma-plasma-inc/49379b63-8be6-4f78-902f-f9890f82efbd)
- [CGG Medical Inc](https://www.keypedia.com/companies/cgg-medical-inc/40a6e751-f818-455e-bd9c-7c1dd3017021)
- [Christopher Romero, M.D.](https://www.keypedia.com/companies/christopher-romero-md/08048426-d161-459f-aba0-8ce414e6a13a)
- [New Hope Fertility Center](https://www.keypedia.com/companies/new-hope-fertility-center/33ad3890-9505-42e3-aa1f-236cd8505bad)
- [Jonathan E. Isaacs, M.D.](https://www.keypedia.com/companies/jonathan-e-isaacs-md/f06372ab-9d9e-45f5-a82c-7692ce07dd95)
- [CSL Plasma Inc.](https://www.keypedia.com/companies/csl-plasma-inc/5f271052-7d17-4ed5-922b-00267b8d77fb)
- [BioLife Plasma Services LP](https://www.keypedia.com/companies/biolife-plasma-services-lp/28b77936-d449-4bd5-a6bf-b81fc6582d2f)
- [William J. Muller, M.D.](https://www.keypedia.com/companies/william-j-muller-md/fb609072-8eac-408a-9539-13f3f8c5b265)
- [Genetech Inc](https://www.keypedia.com/companies/genetech-inc/00af7a0b-75ce-4c2a-865d-6580b0ff15e5)
- [Wendy C. Daly, M.D.](https://www.keypedia.com/companies/wendy-c-daly-md/e730d1a7-8622-4c23-ad76-a1c1c283b89b)

## Related Officers

- [Ivan E. Reyes](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)
- [Program Division Director](https://www.keypedia.com/people/michael-w-roosevelt/136906d6-8e93-4080-acf9-5d48d4509a80)
